Best Medication for Chronic Lumbar Pain
For chronic lumbar pain, NSAIDs are the first-line pharmacological option, with duloxetine (an SNRI) as the preferred second-line agent when NSAIDs are insufficient or contraindicated. 1
First-Line: NSAIDs
NSAIDs demonstrate small to moderate pain relief for chronic low back pain, though the benefits are smaller than previously thought 1. Among NSAIDs, COX-2 selective agents show the strongest evidence with a standardized mean difference of -12.03 for pain relief 2. The 2017 American College of Physicians systematic review—the highest quality guideline evidence available—establishes NSAIDs as the primary pharmacological option 1.
Key considerations for NSAIDs:
- Use the lowest effective dose for the shortest duration
- Monitor for gastrointestinal, cardiovascular, and renal adverse effects
- Consider COX-2 selective agents to reduce GI risk in appropriate patients
- Contraindicated in patients with cardiovascular disease, renal impairment, or active peptic ulcer disease
Second-Line: Duloxetine (SNRI)
Duloxetine is the only antidepressant with robust evidence for chronic low back pain 1. The ACP guideline specifically identifies duloxetine as effective with modest benefits (NNT = 10) 3. This makes it particularly valuable when NSAIDs fail or are contraindicated.
Duloxetine profile:
- Number needed to treat: 10
- Number needed to harm (discontinuation due to adverse events): 11
- The benefit-to-harm ratio is nearly balanced, making patient selection important
- Most effective for patients with neuropathic or nociplastic pain components
What NOT to Use
Avoid these medications based on guideline evidence:
- Acetaminophen: Proven ineffective for both acute and chronic low back pain 1
- Benzodiazepines: Ineffective for radiculopathy and chronic pain 1
- Systemic corticosteroids: Not effective 1
- Skeletal muscle relaxants: Only effective for acute pain with significant sedation; no role in chronic pain 1
Opioids: Use with Extreme Caution
Opioids show only modest short-term effects for chronic low back pain 1. The harm profile is concerning: NNT = 16 for benefit versus NNH = 5 for discontinuation due to adverse events 3. This unfavorable risk-benefit ratio, combined with addiction potential and the opioid crisis, makes opioids inappropriate for routine chronic low back pain management 4, 5.
If opioids are considered (rare circumstances only):
- Reserve for severe pain unresponsive to all other treatments
- Use lowest dose for shortest duration
- Implement strict monitoring protocols
- Consider partial opioid agonists (like buprenorphine) which show better safety profiles 2
Treatment Algorithm
Start with NSAIDs (preferably COX-2 selective if no contraindications)
- If inadequate response after 2-4 weeks → proceed to step 2
- If contraindicated → proceed directly to step 2
Add or switch to duloxetine (especially if neuropathic features present)
- Start 30mg daily, increase to 60mg after 1 week
- Assess response at 4-8 weeks
If both fail, consider:
Critical Pitfalls to Avoid
- Do not prescribe acetaminophen—it wastes time and money with no benefit 1
- Do not use muscle relaxants chronically—they cause sedation without functional improvement 1
- Do not reflexively prescribe opioids—the harm-to-benefit ratio is unacceptable for chronic non-cancer pain 3, 4, 5
- Do not continue ineffective medications—reassess at 4 weeks and discontinue if no meaningful improvement
Important Context
All effective medications provide only small to moderate, primarily short-term pain relief 1. Pain improvements are generally greater than functional improvements 1. Exercise is the only intervention with sustained benefit extending beyond the treatment period 3, making pharmacotherapy an adjunct to—not replacement for—physical rehabilitation and activity modification.
The goal of medication is to reduce pain enough to enable participation in physical therapy and maintain activity, not to eliminate pain completely 6, 7.